CPRX

[setravis]

Did this come across your radar today ?
More on this one later, keep your eye on this pup!

[sumfolio]

We've been watching this one as well... their CPP-109 clinical data slated to be presented on April 16th during the American Society of Addiction Medicine meeting. Investors were hoping that it would be new data, but recent news has dampened those hopes.

From an AP report today:

"Catalyst said the National Institute on Drug Abuse will cover most of the costs of a new midstage clinical trial of CPP-109, which is also called vigabatrin. The drug intended to help break addiction, but clinical trials involving cocaine and methamphetamine addicts have not been successful."

However, the company noted:

"According to Catalyst, the last trial of vigabatrin in cocaine addiction failed because not enough patients took the drug. The company said an independent panel agreed there was enough evidence the drug helped patients stay off cocaine. Vigabatrin's effectiveness against methamphetamine was not much different from a placebo, although Catalyst said that result was also encouraging."

Nevertheless, April 16th could be a day to watch this one.

[setravis]

updated chart look.

Below the 6 month chart.......